Fabio D'Aguiar Mataveli, pharmaceutical executive, researcher. Achievements include first to public reimbursement of imatinib for CML patients.
Education
Doctor of Medicine, State University of Campinas-State University Campinas, Brazil, 2000. Master of Business Administration in Corporation Finance, Fundação Getúlio Vargas, 2002. Doctor of Philosophy, Federeal University São Paulo-UNIFESP, São Paulo, 2009.
Degree in Health Economics, Faculty Public Health-State University São Paulo, 2006.
Career
Market access and health economics manager Novartis Oncology, São Paulo, 2006—2007. Regional market access and professional education manager Johson & Johnson, since 2008. Health economics and biotechnology consultant Anvisa-Unesco, Brasilia, District of Columbia, Brazil, 2004—2005.